Market revenue in 2023 | USD 10.3 million |
Market revenue in 2030 | USD 15.8 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 46.6% in 2023. Horizon Databook has segmented the Canada cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
The healthcare industry in Canada is growing due to increasing prevalence of chronic diseases and aging population. In 2016, total healthcare expenditure was approximately USD 171.77 billion. The large elderly population is responsible for increasing demand for healthcare services and rising spending on associated services.
Furthermore, increasing prevalence of chronic diseases, rising awareness about advanced technologies among patients, along with expectations regarding better healthcare facilities at affordable costs are anticipated to drive the growth of cannula market in Canada.
The elderly population is projected to increase at an annual rate of 3.8% in the coming years. Sales of products such as such as cardiovascular and neurological devices, which support the elderly, are expected to increase over the next five years. In addition, the Canadian government is investing in innovations such as data analytics, artificial intelligence, and precision medicine to improve patient health and reduce spending.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account